运动神经元疾病的突破性药物在新的研究中显示出希望 诸平 Key Highlights: Ellorarxine, a novel drug compound developed by Nevrargenics, has demonstrated antioxidant and anti-inflammatory effects, which make it a promising new therapy for treating ALS. The results showed that Ellorarxine in ...